Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase

Survival rates of children with acute lymphoblastic leukemia have improved since the incorporation of asparaginase in the treatment protocol, but the medication has potential serious complications, including vascular thrombosis. Here, we describe the case of a 13-year-old boy with pre-T-cell acute l...

Full description

Saved in:
Bibliographic Details
Published in:Radiology case reports 2018-06, Vol.13 (3), p.568-572
Main Authors: Tang, Elizabeth R, Chapman, Teresa, Finn, Laura S, Leger, Kasey J
Format: Article
Language:English
Subjects:
Pediatric
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Survival rates of children with acute lymphoblastic leukemia have improved since the incorporation of asparaginase in the treatment protocol, but the medication has potential serious complications, including vascular thrombosis. Here, we describe the case of a 13-year-old boy with pre-T-cell acute lymphoblastic leukemia whose treatment course was complicated by perforated jejunitis requiring resection of a portion of his small bowel. Pathologic assessment showed transmural ischemia, mesenteric venous and arterial thrombi, and scattered cytomegalovirus inclusion bodies. Pediatric mesenteric ischemia is rare, and its consideration in patients treated with asparaginase is discussed.
ISSN:1930-0433
1930-0433
DOI:10.1016/j.radcr.2018.02.017